NewEdge Advisors’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

NewEdge Advisors’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54	Closed	-$242	–	4001
2023 Q4	$242	Sell	54 -6	-10%	-$21	﹤0.01%	3592
2023 Q3	$363	Hold	60	–	–	﹤0.01%	3281
2023 Q2	$736	Hold	60	–	–	﹤0.01%	3286
2023 Q1	$860	Hold	60	–	–	﹤0.01%	3179
2022 Q4	$1	Buy	+60	New	+$1.73K	﹤0.01%	4063

NewEdge Advisors's MDVL Position: Q1 2024 in Review

NewEdge Advisors sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 54 shares — an estimated $242 sold.

NewEdge Advisors first reported a position in MDVL in Q4 2022 and held it in 5 quarters. The position peaked at $860 in Q1 2023. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

NewEdge Advisors reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
NewEdge Advisors sold 54 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $242.
NewEdge Advisors first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
NewEdge Advisors's MedAvail Holdings, Inc. Common Stock position peaked at $860 in Q1 2023.
1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on NewEdge Advisors's 13F filing for Q1 2024, filed 14 May 2024.